SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-22-280728
Filing Date
2022-11-09
Accepted
2022-11-09 07:56:30
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 d419056ds3.htm S-3 203746
2 EX-5.1 d419056dex51.htm EX-5.1 6289
3 EX-23.1 d419056dex231.htm EX-23.1 1602
4 EX-FILING FEES d419056dexfilingfees.htm EX-FILING FEES 24620
5 GRAPHIC g419056g01k04.jpg GRAPHIC 82926
6 GRAPHIC g419056g1109043336203.jpg GRAPHIC 2984
  Complete submission text file 0001193125-22-280728.txt   355865
Mailing Address 880 WINTER STREET WALTHAM MA 02451
Business Address 880 WINTER STREET WALTHAM MA 02451 857-399-9500
TScan Therapeutics, Inc. (Filer) CIK: 0001783328 (see all company filings)

IRS No.: 825282075 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-268261 | Film No.: 221370703
SIC: 2836 Biological Products, (No Diagnostic Substances)